Biofrontera BFRI
NASDAQ BFRI
$0.78 -0.02 (-2.50%)
At close: Oct 22, 2026 · 4:00 PM EDT

Biofrontera (BFRI) Work In Process (2026)

Updated

Biofrontera (BFRI) reported Work In Process of $67,000 for Q2 2026.

Analysis

Biofrontera (BFRI) Work In Process (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn
10 Biofrontera 10.22 Mn -11.58 Mn 9.59 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 67,000.00
API Access

Biofrontera Work In Process API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=work-in-process&ticker=BFRI&period=max&api_key=YOUR_API_KEY